Concepedia

Publication | Closed Access

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

46

Citations

0

References

2009

Year

Abstract

clinicaltrials.gov Identifier: NCT00161031.